Year 2021 đđđ
The authors developed a vaccine against a membrane-bound seno-antigen called GPNMB and show that it can be used as a new senolytic approach. The vaccine led to improvements of several age-related phenotypes and prolonged the lifespan of a progeroid mouse model.
Leave a reply